Chewy (CHWY) Is Up 12.4% After AI And Automation Expansion With New Term Loan Financing

• In late June 2026, Chewy, Inc. announced it is expanding its use of artificial intelligence and automation across customer service, pharmacy operations, fulfillment, and marketing after building the technical infrastructure earlier in the year.
• At the same time, Chewy secured a US$600.0 million seven-year senior secured term loan and extended its asset-based lending facility to 2031, signaling a focus on both operational efficiency and long-term funding flexibility.
• We’ll now examine how Chewy’s broader AI and automation push could influence its investment narrative built around Autoship and vet clinics.

We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Chewy Investment Narrative Recap

To own Chewy, you need to believe its Autoship engine and newer vet services can offset modest customer growth and heavy competition in pet e-commerce. The AI and automation push, paired with fresh funding, directly ties into the key near-term catalyst of margin improvement, but it does not remove core risks around reliance on subscriptions and slowing new customer additions.

The new US$600.0 million seven-year term loan stands out here because it underpins Chewy’s ability to roll out AI across fulfillment, customer service, and pharmacy. That matters for investors focused on whether automation can actually support its long-term 10 percent adjusted EBITDA margin ambition while Chewy invests in Chewy Vet Care Clinics and its ads platform.

Yet, against this, investors should also weigh the risk that Chewy’s heavy reliance on Autoship and online-only delivery could become a problem if...

Read the full narrative on Chewy (it's free!)

Chewy's narrative projects $15.7 billion revenue and $569.8 million earnings by 2029. This requires 6.8% yearly revenue growth and about a $314.6 million earnings increase from $255.2 million today.

Uncover how Chewy's forecasts yield a $31.05 fair value, a 49% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming Chewy could reach about US$16.5 billion in revenue and roughly US$683.7 million in earnings by 2029, so if AI driven efficiencies and vet services scale faster than expected, their view looks very different to more cautious takes on subscription risk and competition, and it is worth you comparing those contrasting paths for yourself.

Explore 4 other fair value estimates on Chewy - why the stock might be worth just $31.05!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Chewy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Chewy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chewy's overall financial health at a glance.

Want Some Alternatives?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com